Biological activity associated with a high molecular weight form of β-amyloid

Alzheimer's Reports

Volumn 2, Issue 3, 1999, Pages 171-177

  Howlett, David R ^a   Ward, Robin V ^a   Bresciani, Laura ^a   Jennings, Kevin H ^a   Christie, Gary ^a   Allsop, David ^a   Gray, Carol W ^a   Karran, Eric H ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000987783     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Behl C, Davis J, Cole GM and Schubert D (1992. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem Biophys Res Comm 186, 944-950.
2. Behl C, Davis JB, Lesley R and Schubert D (1994). Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
3. Butterfield DA, Hensley K, Harris M et al. (1994). β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Comm 200, 710-715.
4. Forloni G, Chiesa R, Smiroldo S et al. (1993). Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. NeuroReport 4, 523-526.
5. Hansen MB, Nielsen SE and Berg K (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Meth 119, 203-210.
6. Hardy J and Allsop D (1991). Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12, 383-388.
7. Harper JD, Lieber CM and Lansbury PT (1997). Atomic-force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's-disease amyloid-β protein. Chem Biol 4, 951-959.
8. Hartmann T, Bieger SC, Bruhl B et al. (1997). Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nature Med 3, 1016-1020.
9. Hensley K, Carney JM, Mattson MP et al. (1994). A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc NatlAcad Sci USA 91, 3270-3274.
10. Howlett D, Cutler P, Heales S and Camilleri P (1997), Hemin and related porphyrins inhibit β-amyloid aggregation. FEBS Lett 417, 249-251.
11. Howlett DR, Jennings KH, Lee DC et al. (1995). Aggregation state and neurotoxic properties of Alzheimer β-amyloid peptide. Neurodegeneration 4, 23-32.
12. Ida N, Hartmann T, Pantel J et al. (1996). Analysis of heterogeneous β-A4 peptides in human cerebrospinal-fluid and blood by a newly developed sensitive western-blot assay. J Biol Chem 271, 22908-22914.
13. Iversen LL, Mortishiresmith RJ, Pollack SJ and Shearman MS (1995). The toxicity in vitro of β-amyloid protein. Biochem J 311, 1-16.
14. Koh JY, Yang LL, Cotman CW (1990). β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 533, 315-320.
15. Laemmli UK and Favre M (1973). Maturation of the head of bacteriophage T4. 1. DNA packaging events. J Mol Biol 80, 575-599.
16. Lambert MP, Barlow AK, Chromy BA et al. (1998). Diffusible, nonfibrillar ligands derived from Aβ(1-42) are potent central-nervous-system neurotoxins. Proc Natl Acad Sci USA 95, 6448-6453.
17. Liu YB and Schubert D (1997). Cytotoxic amyloid peptides inhibit cellular 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neurochem 69, 2285-2293.
18. Loo DT, Copani A, Pike CJ et al. (1993). Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90, 7951-7955.
19. Mattson MP, Cheng B, Davis D et al. (1992). β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12, 376-389.
20. May PC, Gitter BD, Waters DC et al. (1992). β-amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol Aging 13, 605-607.
21. Merlini G, Ascari E, Amboldi N et al. (1995). Interaction of the anthracycline 4′-iodo-4′-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci USA 92, 2959-2963.
22. Oda T, Wals P, Osterburg HH et al. (1995). Clusterin (ApoJ) alters the aggregation of amyloid β-peptide (Aβ 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp Neurol 136, 22-31.
23. Pike CJ, Walencewicz AJ, Glabe CG and Cotman CW (1991 a). Aggregation-related toxicity of synthetic β-amyloid protein in hippocampa! cultures. Eur J Pharmacol 207, 367-368.
24. Pike CJ, Walencewicz AJ, Glabe CG and Cotman CW (1991b). In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563, 311-314.
25. Podlisny MB, Walsh DM, Amarante P et al. (1998). Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell-culture and stabilization of monomer by congo red. Biochemistry 37, 3602-3611.
26. Roher AE, Chaney MO, Kuo YM, et al. (1996). Morphology and toxicity of Aβ(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem 271, 20631-20635.
27. Shearman MS, Ragan CI and Iversen LL (1994). Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc Natl Acad Sci USA 91, 1470-1474.
28. Stine WB, Snyder SW, Ladror US et al. (1996). The nanometer-scale structure of amyloid-β visualized by atomic-force microscopy. J Protein Chem 15, 193-203.
29. Towbin H, Staehelin T and Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76, 4350-4354.
30. Walsh DM, Lomakin A, Benedek GB et al. (1997). Amyloid β-protein fibrillogenesis - detection of a protofibrillar intermediate. J Biol Chem 272,22364-22372.
31. Wood SJ, Mackenzie L, Maleeff B et al. (1996a). Selective inhibition of Aβ fibril formation. J Biol Chem 271, 4086-4092.
32. Wood SJ, Maleeff B, Hart T and Wetzel R (1996b). Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ J Mol Biol 256, 870-877.
33. Yankner BA, Dawes LR, Fisher S et al. (1989). Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420.
34. Yankner BA, Duffy LK and Kirschner DA (1990). Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282.